The regulation of the Turkish Agency for Medicines and Medical Devices for the supply of medicines abroad has been published.

It will be mandatory to have a resident representative in Turkey for medicines supplied from abroad.

In accordance with the regulations published in this edition of the Official Gazette, foreign pharmaceutical suppliers may become representatives as long as they comply with the corresponding obligations.

REQUEST FOR SUPPLY OF BULK MEDICINES IN HOSPITALS ONLY

It was mandatory that the representative of medicines for human use be exclusively authorized for the activities to be carried out in Turkey within the scope of the regulation of the medicine for human use in question.

Requests for the supply of bulk medicines from abroad will only be made by hospitals in accordance with the guidelines published by the Turkish Agency for Medicines and Medical Devices.

With the exception of collective procurement, no institution or organization can submit a direct request to the institution within the scope of the procurement of medicines from abroad.

IMPORT PERMITS WILL BE CANCELED

The institution can impose all kinds of sanctions provided for in the relevant legislation, including import restrictions, and can issue a decision prohibiting activities to foreign pharmaceutical suppliers and representatives that do not comply with the provisions of the regulation.

Existing import permits of foreign drug suppliers, whose ban decision has been implemented, will be cancelled.

In the implementation of the provisions of the regulation, a gradual transition is expected on dates that change until June. (Reuters)